Related Experiment Video

Updated: Feb 28, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K

Nanotechniques Inactivate Cancer Stem Cells

Anatoliy N Goltsev1, Natalya N Babenko2, Yulia A Gaevskaya2

  • 1Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine. cryopato@gmail.com.

Nanoscale Research Letters
|June 18, 2017
PubMed

Insights

This study identifies cancer stem cells within Ehrlich carcinoma, demonstrating CD44+ cells possess higher tumorigenic potential. Hybrid nanocomplexes effectively inhibited tumor growth by targeting these cancer stem cells.

Area of Science:

  • Oncology
  • Cancer Stem Cell Biology
  • Nanomedicine

Background:

  • Cancer stem cells (CSCs) are crucial for tumor growth and recurrence.
  • Identifying CSCs and developing targeted therapies is a key challenge in oncology.
  • Ehrlich carcinoma serves as a model to study CSCs and their therapeutic inhibition.

Purpose of the Study:

  • To characterize Ehrlich carcinoma cells and identify CSCs.
  • To evaluate the therapeutic potential of novel hybrid nanocomplexes for cancer treatment.
  • To investigate the role of CD44+ and CD44- subpopulations in tumor growth.

Main Methods:

  • Phenotypic characterization of Ehrlich carcinoma cells.
  • Assessment of tumorigenic activity of CD44+ and CD44- subpopulations.
  • Treatment with hybrid nanocomplexes (GdYVO4:Eu3+ and cholesterol).
  • Flow cytometry analysis of cell subpopulations (CD44, CD24, CD117).

Main Results:

  • Ehrlich carcinoma contains CSCs, with CD44+ cells exhibiting significantly higher tumorigenic activity (tenfold) than CD44- cells.
  • CD44+ cells generated CD44high, CD44+CD24-, and CD44+CD24+ subpopulations, confirming CSC presence.
  • Hybrid nanocomplex treatment reduced CD44high cells and increased CD117+ cells.
  • Tumor growth intensity was reduced by 74.70% ± 4.38% in the treated group compared to the control.

Conclusions:

  • Cancer stem cells are present in Ehrlich carcinoma and are enriched within the CD44+ subpopulation.
  • Synthesized hybrid nanocomplexes demonstrate significant tumor-inhibiting effects.
  • These nanocomplexes offer a promising therapeutic strategy by targeting cancer stem cells in Ehrlich carcinoma.
Keywords:
Cancer stem ellsEhrlich carcinoma cellsNanocomplexes

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.1K